ArticleAntibody therapeutics2025
Overcoming antigen tolerance to develop GB22-45-2, an anti-DKK1 antibody for gastric cancer.
Wenjun Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleAntibody therapeutics2025
Wenjun Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.